|1.||Ziganshina, L E: 2 articles (11/2015 - 09/2002)|
|2.||Reznik, V S: 2 articles (09/2013 - 01/2002)|
|3.||Malyshev, K V: 2 articles (01/2002 - 01/2000)|
|4.||Fazlleeva, G M: 1 article (12/2015)|
|5.||Gulenova, M V: 1 article (12/2015)|
|6.||Kochetkov, E N: 1 article (12/2015)|
|7.||Melnikova, N B: 1 article (12/2015)|
|8.||Nuretdinov, I A: 1 article (12/2015)|
|9.||Korobko, V M: 1 article (12/2015)|
|10.||Poddel'sky, A I: 1 article (12/2015)|
|1.||Wounds and Injuries (Trauma)
12/01/2015 - "The antioxidant and regenerating effects were shown when treating wounds by xymedon(®) in the presence of additives (0.001%) of (NO)2-MF in the experiments on the rats. "
10/01/2006 - "4. It is suggested that the positive effects of Xymedon on neural regeneration and recovery of motor function support the potential use of Xymedon for the treatment of peripheral nerve injuries."
01/01/1991 - "In the experiment on 173 rats the stimulating effect of xymedon on the processes of reparative regeneration in a wound was established. "
01/01/1991 - "[The effect of xymedon on healing of linear wounds]."
03/01/1999 - "The positive results of experimental studies and clinical observations suggest that wound adapters have promises in practical application, transtissue device-aided vulnosynthesis in combination with topical pyrimidine derivatives, such as ximedon, shows great opportunities in soft tissue lesions."
07/01/1993 - "[The use of xymedon in treating trophic ulcers of the lower extremities]."
07/01/1993 - "A new derivative of pyrimidine--Ximedon--was included in the complex treatment of 50 patients with trophic ulcers of lower extremities. "
01/01/2002 - "Ximedone implementation for complex treatment of burns, trophic ulcer of lower limbs, different inflammations demonstrated positive results. "
|5.||Body Weight (Weight, Body)
11/27/2015 - "The groups were as follows: 1st group - intact animals (control); 2nd group - animals to whom the solvent (distilled water) was administered with intra-gastric tube in corresponding volume (control of the model); 3rd - 8th study groups, in which animals were administered with study agents each at a dose of 1 mmol/kg body weight: dimephosphone, ephorane, mephoprane, xymedon, etindronate and prednisolone. "
01/01/1995 - "The rabbits were fed either a chow containing cholesterol (200 mg/kg body weight) or the same diet also containing xymedon (30 mg/kg body weight) or pyridinol carbamate (30 mg/kg body weight). "
|5.||Etidronic Acid (HEDP)